Systematic Review
Accepted on 11 May 2026
Reduced-Intensity Versus Intensive Induction in High-Risk Acute Promyelocytic Leukemia: A Systematic Review and Meta-Analysis
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
Type at least 3 characters
191 articles
articles
Review
Published on 11 May 2026
Bridging innovation and equity: the evolving landscape of CAR T-cell therapy access in Brazil
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2026.1813861
- 479 views
Hypothesis and Theory
Accepted on 06 May 2026
The cells of origin of the chemotherapy curable malignancies are highly sensitive to cytotoxic chemotherapy mediated cell death
in Blood Cancer
Frontiers in Hematology
- 104 views
Original Research
Published on 04 May 2026
Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1800304
- 590 views
Mini Review
Accepted on 17 Apr 2026
Mechanisms of Kinase Inhibitor Resistance in Subtypes of Cutaneous T-Cell Lymphomas
in Blood Cancer
Frontiers in Hematology
- 395 views
Case Report
Published on 13 Apr 2026
Case Report: Pernicious anemia-associated pancytopenia responds to immunotherapy
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2026.1733719
- 427 views
Original Research
Accepted on 08 Apr 2026
A pilot study on therapeutic drug monitoring of Asparaginase in Indian children with high-Risk ALL: Evidence for Suboptimal Exposure
in Blood Cancer
Frontiers in Hematology
- 417 views
Case Report
Published on 08 Apr 2026
Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1650494
- 1,031 views
Review
Published on 31 Mar 2026
Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1749376
- 1,209 views
Case Report
Published on 30 Mar 2026
Case Report: Burkitt’s lymphoma with concurrent HIV, CMV encephalitis, and salmonella bacteremia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1727954
- 430 views
Original Research
Published on 30 Mar 2026
Complications and treatment patterns in patients with non-transfusion-dependent α- and β-thalassemia compared with matched controls: a retrospective observational study using administrative claims data in the United States
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2026.1770034
- 582 views
Editorial
Published on 27 Mar 2026
Editorial: Advances and new horizons in cellular therapies for leukemia and myeloma
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2026.1812817
- 394 views
Perspective
Published on 26 Mar 2026
Castleman disease mimicking systemic lupus erythematosus: the importance of vigilance in diagnosing autoimmune mimickers
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2026.1785387
- 513 views
Methods
Published on 18 Mar 2026
Single spectral flow cytometry panel for simultaneous detection of hematopoietic stem, progenitor, and mature lineages in mouse bone marrow
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2026.1802350
- 1,053 views
Original Research
Published on 16 Mar 2026
Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1794624
- 855 views
Case Report
Published on 23 Feb 2026
Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1745884
- 766 views
- 1 citation
Case Report
Published on 23 Feb 2026
Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1776722
- 457 views
Review
Published on 23 Feb 2026
The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2026.1686097
- 504 views
Original Research
Published on 12 Feb 2026
Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1709697
- 836 views
Case Report
Published on 04 Feb 2026
Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1748301
- 841 views
Original Research
Published on 30 Jan 2026
Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1733667
- 1,554 views
Editorial
Published on 27 Jan 2026
Editorial: Innovations and challenges in sickle cell disease: bridging gaps in global health
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2026.1787190
- 1,018 views
Case Report
Published on 23 Jan 2026
Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1683981
- 1,297 views
Case Report
Published on 23 Jan 2026
Daratumumab in severe Evans syndrome: a case report
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1719208
- 1,350 views